EUVIMEDSkopri EUVIMED
Open access

Clinically meaningful individual differences in opioid withdrawal expression.

Orrin D Ware iD, Kelly E Dunn

Experimental and Clinical Psychopharmacology · 2023

DOI: 10.1037/pha0000654 ↗

At a glance

Journal article in Experimental and Clinical Psychopharmacology, 2023. Written by Orrin D Ware and 1 co-authors. Institution: School of Social Work, University of North Carolina at Chapel Hill. Major MEDLINE topics: Opioid-Related Disorders, Substance Withdrawal Syndrome. Cited 9 times so far (Crossref). The full text is freely available in PubMed Central. Funded by: NIDA NIH HHS, National Institutes of Health.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Opioid use disorder (OUD) is a significant public health concern. An individual with an OUD may experience withdrawal after stopping opioid use. There has been limited exploration of the individual differences in withdrawal expression. This study expands understanding of this issue by examining the presence and frequency at which persons who have ever had opioid withdrawal have experienced different opioid withdrawal symptoms. Using cross-sectional data captured online from Amazon Mechanical Turk, 124 adults with a lifetime experience of opioid withdrawal were included. Respondents were able to indicate ever experiencing 31 individual opioid withdrawal symptoms. If a symptom was ever experienced, respondents would indicate if it was common and whether it bothered them. A cluster analysis was used to explore variability between the withdrawal symptoms. The sample was primarily men (n = 76, 61.3%) with an average age of 34.7 (SD = 11.6). The typical withdrawal syndrome lasted 6.5 days (SD = 4.9) and was most severe at 5.7 (SD = 4.9) days. Lifetime endorsement of individual symptoms ranged from a high of 73.4% (anxious) to a low of 43.5% (nausea). The cluster analysis was significant, F(1, 122) = 215.6, p < .001, with good Bayesian information criteria (0.7). The two clusters are conceptualized here as HIGH (N = 73; 59%) and LOW (N = 51; 41%) endorsing, with a mean of 21.9 and 8.5 items endorsed. These data add to prior studies by suggesting high variability in the individual expression of opioid withdrawal symptoms. It may be time for the field to develop a consensus regarding opioid withdrawal symptom expression and measurement to enhance clinical care. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

Subjects

MeSH terms (MEDLINE)

Opioid-Related DisordersSubstance Withdrawal SyndromeMaleAdultHumansAnalgesics, OpioidNarcotic AntagonistsIndividualityBayes TheoremCross-Sectional Studies

Substances

Analgesics, OpioidNarcotic Antagonists

Authors and institutions

  • School of Social Work, University of North Carolina at Chapel Hill.
  • Department of Psychiatry and Behavioral Sciences, Behavioral Pharmacology Research Unit, Johns Hopkins University School of Medicine.

ORCID profiles: Orrin D Ware

Funding

  • NIDA NIH HHS
  • National Institutes of Health

Cite

APA

Ware, O. D., & Dunn, K. E. (2023). Clinically meaningful individual differences in opioid withdrawal expression. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/pha0000654

Vancouver

Ware OD, Dunn KE. Clinically meaningful individual differences in opioid withdrawal expression. Experimental and Clinical Psychopharmacology. 2023. doi:10.1037/pha0000654

BibTeX
@article{Ware2023,
  author = {Ware, Orrin D and Dunn, Kelly E},
  title = {Clinically meaningful individual differences in opioid withdrawal expression},
  journal = {Experimental and Clinical Psychopharmacology},
  year = {2023},
  doi = {10.1037/pha0000654}
}
Start for free →